9Rantala AO,Kauma H,LiJia M,et al.Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects[J].J Inter Med,1999,245:163-74.
10GreenLund KJ,Valdez R,Casper ML,et al.Prevalence and correlates of the insulin resistance syndrome.among native Americans[J].DiabetsCare.1999,22:441-447.
2Ninomiya JK, L' Italien G, Criqui MH, et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey[J]. Circulation, 2004,109:42-46.
3Cohn G, Valdes G, Capuzzi DM. Pathophysiology and treatment of the dyshpidemia of insulin resistance[J]. Curr Cardiol Rep,2001,3:416-423.
4Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in conmatmity-dwelling older adults: the Rancho Bemardo Study [ J ]. Metabolism, 2002,51:356-359.
5Vitalian PP, Scanlan JM, Zhang J, et al. A path model of chronic stress, the metabolic syndrome, and coronary heart disease[J]. Psychosom Med, 2002,64: 418-435.
6Bjomtorp P. Do stress reactions cause abdominal obesity and comorbidities[J]. Obes Rev,2001,2:73-86.
7Whorwood CB, Donovan S J, Flanagan D, et al. Increased glucocorticoid receptor expression in skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome[J]. Diabetes, 2002, 51 :1066-1075.
8Isomaa B, Aimgren P, Tuomi T, et al. Cardiovasetdax morbidity and mortality associated with the metabolic syndrome[J]. Diabetes Care,2001,24: 683-689.
9Boden WE. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Demity Lipoprotein Intervention Trial[Jl. Am J Cardiol. 2000,86(12A) :19L-22L.
10Groop L, Orho-Melander M. The dysmetabolic syndrome. J Intern Med, 2001, 250:105-120.
